机械通气重症肺炎合并急性低氧性呼吸衰竭:SARS-CoV-2与其他病因的结局比较
这项在约翰霍普金斯医疗系统开展的回顾性队列研究,比较了2020年3月至2021年6月因COVID-19肺炎机械通气的719例成人患者与2016年7月至2019年12月因其他病因肺炎机械通气的1127例成人患者。未校正分析中COVID-19组90天死亡率更高(OR 1.21,95%CI 1.04-1.41)、机械通气时间更长(亚分布HR 0.72,95%CI 0.63-0.81)、呼吸系统静态顺应性更低(32.0 vs 28.4 mL/kg PBW/cm H2O,P<.001)。倾向评分匹配后两组90天死亡率无显著差异(OR 1.04,95%CI 0.81-1.35,P=.85),顺应性和通气比相似,但COVID-19组脱机率更低(亚分布HR 0.81,95%CI 0.65-1.00),90天存活出院率略低但未达统计学显著(亚分布HR 0.83,95%CI 0.68-1.01)。作者认为COVID-19肺炎的机械通气应遵循与其他肺炎相同的循证指南。
要点
- 倾向评分匹配后,COVID-19肺炎与其他病因重症肺炎机械通气患者90天院内死亡率无显著差异(OR 1.04,95%CI 0.81-1.35,P=.85)。
- 匹配后COVID-19组脱机率更低(亚分布HR 0.81,95%CI 0.65-1.00),机械通气时间更长。
- 匹配后两组呼吸系统静态顺应性相似(均差1.82 mL/cm H2O,95%CI -1.53至5.17,P=.28),通气比也相似(均差-0.05,95%CI -0.22至0.11,P=.52)。
- 未校正分析中COVID-19组90天死亡率更高(OR 1.21,95%CI 1.04-1.41)、通气时间更长(亚分布HR 0.72,95%CI 0.63-0.81)、顺应性更低(32.0 vs 28.4 mL/kg PBW/cm H2O,P<.001)。
- 匹配后COVID-19组90天存活出院率略低但未达统计学显著(亚分布HR 0.83,95%CI 0.68-1.01)。
适用人群与场景
- 成人患者(年龄≥18岁),因肺炎在住院前2周内需要机械通气,研究地点为约翰霍普金斯医疗系统。
- COVID-19肺炎组为2020年3月至2021年6月的患者(719例),其他病因肺炎组为2016年7月至2019年12月的患者(1127例)。
研究设计与关键结果
- 研究类型:回顾性队列研究;地点:约翰霍普金斯医疗系统;COVID-19组719例(平均[SD]年龄61.8[15.3]岁;男性442例[61.5%];少数族裔460例[64.0%],白人253例[35.2%]),非COVID-19组1127例(平均[SD]年龄60.9[15.8]岁;男性586例[52.0%];少数族裔459例[40.7%],白人655例[58.1%])。
- 未校正分析:COVID-19组较非COVID-19组90天死亡率更高(OR 1.21,95%CI 1.04-1.41),机械通气时间更长(亚分布HR 0.72,95%CI 0.63-0.81),呼吸系统静态顺应性更低(32.0 vs 28.4 mL/kg PBW/cm H2O;P<.001)。
- 倾向评分匹配分析:两组90天院内死亡率无显著差异(OR 1.04;95%CI 0.81-1.35;P=.85)。
- 倾向评分匹配分析:两组呼吸系统静态顺应性相似(均差1.82 mL/cm H2O;95%CI -1.53至5.17 mL/cm H2O;P=.28),通气比相似(均差-0.05;95%CI -0.22至0.11;P=.52)。
- 倾向评分匹配分析:COVID-19组脱机率更低(亚分布HR 0.81;95%CI 0.65-1.00)。
- 倾向评分匹配分析:COVID-19组90天存活出院率略低但未达统计学显著(亚分布HR 0.83;95%CI 0.68-1.01)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,COVID-19肺炎的机械通气应遵循与其他任何肺炎相同的循证指南。
- 本研究显示,机械通气的重症COVID-19肺炎患者90天死亡率与其他病因重症肺炎相似,但脱机时间更长。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Early observations suggested that COVID-19 pneumonia had a higher mortality rate than other causes of pneumonia.
OBJECTIVE: To compare outcomes between mechanically ventilated patients with pneumonia due to COVID-19 (March 2020 to June 2021) and other etiologies (July 2016 to December 2019).
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted at the Johns Hopkins Healthcare System among adult patients (aged ≥18 years) with pneumonia who required mechanical ventilation in the first 2 weeks of hospitalization. Clinical, laboratory, and mechanical ventilation data were extracted from admission to hospital discharge or death.
EXPOSURES: Pneumonia due to COVID-19.
MAIN OUTCOMES AND MEASURES: The primary outcome was 90-day in-hospital mortality. Secondary outcomes were time to liberation from mechanical ventilation, hospital length of stay, static respiratory system compliance, and ventilatory ratio. Unadjusted and multivariable-adjusted logistic regression, proportional hazards regression, and doubly robust regression were used in propensity score-matched sets to compare clinical outcomes.
RESULTS: Overall, 719 patients (mean [SD] age, 61.8 [15.3] years; 442 [61.5%] were male; 460 [64.0%] belonged to a minoritized racial group and 253 [35.2%] were White) with severe COVID-19 pneumonia and 1127 patients (mean [SD] age, 60.9 [15.8] years; 586 [52.0%] were male; 459 [40.7%] belonged to a minoritized racial group and 655 [58.1%] were White) with severe non-COVID-19 pneumonia. In unadjusted analyses, patients with COVID-19 pneumonia had higher 90-day mortality (odds ratio, 1.21, 95% CI 1.04-1.41), longer time on mechanical ventilation (subdistribution hazard ratio 0.72, 95% CI 0.63-0.81), and lower compliance (32.0 vs 28.4 mL/kg PBW/cm H2O; P < .001) when compared with those with non-COVID-19 pneumonia. In propensity score-matched analyses, patients with COVID-19 pneumonia were equally likely to die within 90 days as those with non-COVID-19 pneumonia (odds ratio, 1.04; 95% CI, 0.81 to 1.35; P = .85), had similar respiratory system compliance (mean difference, 1.82 mL/cm H2O; 95% CI, -1.53 to 5.17 mL/cm H2O; P = .28) and ventilatory ratio (mean difference, -0.05; 95% CI, -0.22 to 0.11; P = .52), but had lower rates of liberation from mechanical ventilation (subdistribution hazard ratio, 0.81; 95% CI, 0.65 to 1.00) when compared with those with non-COVID-19 pneumonia. Patients with COVID-19 pneumonia had somewhat lower rates of being discharged from the hospital alive at 90 days (subdistribution hazard ratio, 0.83; 95% CI, 0.68 to 1.01) than those with non-COVID-19 pneumonia; however, this was not statistically significant.
CONCLUSIONS AND RELEVANCE: In this study, mechanically ventilated patients with severe COVID-19 pneumonia had similar mortality rates as patients with other causes of severe pneumonia but longer times to liberation from mechanical ventilation. Mechanical ventilation use in COVID-19 pneumonia should follow the same evidence-based guidelines as for any pneumonia.
参考来源
- Nolley EP, Sahetya SK, Hochberg CH, et al. Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies. JAMA Netw Open. 2023. PMID: 36626168. doi:10.1001/jamanetworkopen.2022.50401
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。